Nephrology picture: bone loss due to absence of adequate therapy for severe secondary hyperparathyroidism

J Nephrol. 2022 Dec;35(9):2445-2447. doi: 10.1007/s40620-022-01496-6. Epub 2022 Nov 1.

Authors

Eduardo J Duque¹, Rosilene M Elias^{2

3}, Vanda Jorgetti², Rosa M A Moysés²

Affiliations

¹ Nephrology Department, Laboratório de Investigação Médica 16, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil. eduardojorgeduque@gmail.com.
² Nephrology Department, Laboratório de Investigação Médica 16, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
³ Universidade Nove de Julho (UNINOVE), São Paulo, SP, Brazil.

No abstract available

Keywords: Chronic kidney disease; Osteoporosis; Parathyroidectomy; Secondary hyperparathyroidism.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Humans
Hyperparathyroidism, Secondary* / diagnosis
Hyperparathyroidism, Secondary* / drug therapy
Hyperparathyroidism, Secondary* / etiology
Kidney Failure, Chronic* / therapy
Nephrology*
Parathyroid Hormone
Parathyroidectomy

Substances

Parathyroid Hormone